Effects of recombinant Recombinant luteinizing hormone (rLH) on the outcome of assisted reproductive technology

Not Applicable

• Conditions: infertility.; Habitual aborter, Female infertility, Complications associated with artificial fertilization; N97, N96,

• Registration Number: IRCT201304302575N4
• Lead Sponsor: Yazd research and clinical center for infertility

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

inclusion criteria: infertile women younger than 35 years, serum day 3 Folicle stimulating hormone (FSH) levels <10, male infertility or unexplained infertility and body mass index (BMI) less than 30.

exclusion criteria: azoospermia, uterine myoma, mild endometriosis, Hydrosalpinx, history of previous In vitrofertilization (IVF) (successful or unsuccessful), history of endocrine diseases such as diabetes or thyroid disorders and patients who had hysteroscopic surgery due to intrauterine lesions such as uterine sub-mucosal myoma or intrauterine adhesions

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pregnancy rate. Timepoint: one time, after intevention. Method of measurement: B hCG levels.